Showing results (101-110 of 324) with videos related to
Sort By:
Pageof 33
British Journal of Cancer|January 1, 1982
Response of a high-glucuronidase human tumour xenograft to aniline mustardH M Warenius, P Workman, N M BleehenBiochemical Pharmacology|August 15, 1987
Heat-stimulated nitroreductive bioactivation of the 2-nitroimidazole benznidazole in vitroM I Walton, N M Bleehen, P WorkmanBritish Journal of Cancer|May 1, 1987
The effects of whole body hyperthermia on the pharmacokinetics and toxicity of the basic 2-nitroimidazole radiosensitizer Ro 03-8799 in miceM I Walton, N M Bleehen, P WorkmanBritish Journal of Cancer|March 1, 1979
Pharmacokinetic considerations in testing hypoxic cell radiosensitizers in mouse tumoursJ M Brown, N Y Yu, P WorkmanBiochemical Pharmacology|April 15, 1987
Misonidazole and benznidazole inhibit hydroxylation of CCNU by mouse liver microsomal cytochrome P-450 in vitroF Y Lee, P Workman, K H CheesemanBritish Journal of Cancer|August 1, 1984
Patterns of cross-sensitivity in the responses of clonal subpopulations isolated from the RIF-1 mouse sarcoma to selected nitrosoureas and nitrogen mustardsJ G Reeve, K A Wright, P WorkmanAnti-Cancer Drug Design|December 1, 1992
Further examination of 9-alkyl- and sugar-modified anthracyclines in the circumvention of multidrug resistanceH M Coley, P R Twentyman, P WorkmanCancer Communications|July 1, 1991
The role of NAD(P)H: quinone reductase (EC 1.6.99.2, DT-diaphorase) in the reductive bioactivation of the novel indoloquinone antitumor agent EO9M I Walton, P J Smith, P WorkmanNMR in Biomedicine|September 1, 1992
Non-invasive MRS in new anticancer drug developmentP Workman, R J Maxwell, J R GriffithsEuropean Journal of Cancer (Oxford, England : 1990)|January 1, 1990
9-Alkyl, morpholinyl anthracyclines in the circumvention of multidrug resistanceH M Coley, P R Twentyman, P WorkmanPageof 33